{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:50:54Z","timestamp":1782604254843,"version":"3.54.5"},"reference-count":47,"publisher":"Medical Association of Nippon Medical School","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1272\/jnms.83.216","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T22:19:36Z","timestamp":1485469176000},"page":"216-222","source":"Crossref","is-referenced-by-count":27,"title":["A Review of the Pathogenesis of Toxic Epidermal Necrolysis"],"prefix":"10.1272","volume":"83","author":[{"given":"Yuri","family":"Kinoshita","sequence":"first","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehisa","family":"Saeki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Kinoshita Y, Saeki H: A review of toxic epidermal necrolysis management in Japan. Allergol Int 2016; doi: 10.1016\/j.alit.2016.06.001.","DOI":"10.1016\/j.alit.2016.06.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai X, Gomes JA, Gregory DG, Iyer G, Jacobs DS, Johnson AJ, Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DT, Tandon R, Tseng SC, Ueta M, Chodosh J: Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis-A Comprehensive Review and Guide to Therapy. I. Systemic Disease. Ocul Surf 2016; 14: 2-19.","DOI":"10.1016\/j.jtos.2015.10.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, Shear NH: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update. Am J Clin Dermatol 2015; 16: 475-493.","DOI":"10.1007\/s40257-015-0158-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Downey A, Jackson C, Harun N, Cooper A: Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol 2012; 66: 995-1003.","DOI":"10.1016\/j.jaad.2011.09.029"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E, Cozzio A, French LE: Toxic epidermal necrolysis. F1000Res 2016; 5.","DOI":"10.12688\/f1000research.7574.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tohyama M, Hashimoto K: Immunological mechanisms of epidermal damage in toxic epidermal necrolysis. Curr Opin Allergy Clin Immunol 2012; 12: 376-382.","DOI":"10.1097\/ACI.0b013e328355b865"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chung WH, Wang CW, Dao RL: Severe cutaneous adverse drug reactions. J Dermatol 2016; 43: 758-766.","DOI":"10.1111\/1346-8138.13430"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Paquet P, Pierard GE: Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review). Int J Mol Med 2007; 19: 3-10.","DOI":"10.3892\/ijmm.19.1.3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Khalili B, Bahna SL: Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol 2006; 97: 272-280; quiz 81-83, 320.","DOI":"10.1016\/S1081-1206(10)60789-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Abe R: Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Dermatol 2015; 42: 42-48.","DOI":"10.1111\/1346-8138.12674"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Morel E, Escamochero S, Cabanas R, Diaz R, Fiandor A, Bellon T: CD94\/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Allergy Clin Immunol 2010; 125: 703-710, 10 e1-10 e8.","DOI":"10.1016\/j.jaci.2009.10.030"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Pichler WJ, Beeler A, Keller M, Lerch M, Posadas S, Schmid D, Spanou Z, Zawodniak A, Gerber B: Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol Int 2006; 55: 17-25.","DOI":"10.2332\/allergolint.55.17"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yun J, Marcaida MJ, Eriksson KK, Jamin H, Fontana S, Pichler WJ, Yerly D: Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01. J Immunol 2014; 192: 2984-2993.","DOI":"10.4049\/jimmunol.1302306"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Adam J, Pichler WJ, Yerly D: Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol 2011; 71: 701-707.","DOI":"10.1111\/j.1365-2125.2010.03764.x"},{"key":"15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","volume":"486","author":"PT Illing","year":"2012","unstructured":"15. Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J: Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012; 486: 554-558.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B: Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A 2012; 109: 9959-9964.","DOI":"10.1073\/pnas.1207934109"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yang CW, Hung SI, Juo CG, Lin YP, Fang WH, Lu IH, Chen ST, Chen YT: HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome. J Allergy Clin Immunol 2007; 120: 870-877.","DOI":"10.1016\/j.jaci.2007.06.017"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wei CY, Chung WH, Huang HW, Chen YT, Hung SI: Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 2012; 129: 1562-1569 e5.","DOI":"10.1016\/j.jaci.2011.12.990"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT: HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 2005; 102: 4134-4139.","DOI":"10.1073\/pnas.0409500102"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chung WH, Hung SI, Chen YT: Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 2007; 7: 317-323.","DOI":"10.1097\/ACI.0b013e3282370c5f"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT: Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.","DOI":"10.1038\/428486a"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault-Villada I, Bensussan A, Roujeau JC: Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol 2000; 119: 225-230.","DOI":"10.1046\/j.1365-2249.2000.01119.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yang Y, Li F, Du J, Shen Y, Lin J, Zhu X, Luo X, Liang J, Xu J: Variable levels of apoptotic signal-associated cytokines in the disease course of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Australas J Dermatol 2016; doi: 10.1111\/ajd.12462.","DOI":"10.1111\/ajd.12462"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B, Kappeler A, von Greyerz S, Braathen LR, Pichler WJ: T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31: 1398-1408.","DOI":"10.1046\/j.1365-2222.2001.01164.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T: Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009; 182: 8071-8079.","DOI":"10.4049\/jimmunol.0804002"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fujiyama T, Kawakami C, Sugita K, Kubo-Kabashima R, Sawada Y, Hino R, Nakamura M, Shimauchi T, Ito T, Kabashima K, Hashizume H, Tokura Y: Increased frequencies of Th17 cells in drug eruptions. J Dermatol Sci 2014; 73: 85-88.","DOI":"10.1016\/j.jdermsci.2013.08.008"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Louten J, Boniface K, de Waal Malefyt R: Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 2009; 123: 1004-1011.","DOI":"10.1016\/j.jaci.2009.04.003"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Teraki Y, Kawabe M, Izaki S: Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis. J Allergy Clin Immunol 2013; 131: 907-909.","DOI":"10.1016\/j.jaci.2012.08.042"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gagliani N, Amezcua Vesely MC, Iseppon A, Brockmann L, Xu H, Palm NW, de Zoete MR, Licona-Lim\u00f3n P, Paiva RS, Ching T, Weaver C, Zi X, Pan X, Fan R, Garmire LX, Cotton MJ, Drier Y, Bernstein B, Geginat J, Stockinger B, Esplugues E, Huber S, Flavell RA: Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 2015; 523: 221-225.","DOI":"10.1038\/nature14452"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ang CC, Tay YK: Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Int J Dermatol 2011; 50: 1570-1578.","DOI":"10.1111\/j.1365-4632.2011.05007.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. French LE, Trent JT, Kerdel FA: Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Int Immunopharmacol 2006; 6: 543-549.","DOI":"10.1016\/j.intimp.2005.11.012"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC: Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004; 114: 1209-1215.","DOI":"10.1016\/j.jaci.2004.07.047"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490-493.","DOI":"10.1126\/science.282.5388.490"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H: Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003; 162: 1515-1520.","DOI":"10.1016\/S0002-9440(10)64284-8"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Murata J, Abe R, Shimizu H: Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. J Allergy Clin Immunol 2008; 122: 992-1000.","DOI":"10.1016\/j.jaci.2008.06.013"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H: Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med 2009; 151: 514-515.","DOI":"10.7326\/0003-4819-151-7-200910060-00016"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT: Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14: 1343-1350.","DOI":"10.1038\/nm.1884"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Saito N, Qiao H, Yanagi T, Shinkuma S, Nishimura K, Suto A, Fujita Y, Suzuki S, Nomura T, Nakamura H, Nagao K, Obuse C, Shimizu H, Abe R: An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions. Sci Transl Med 2014; 6: 245ra95.","DOI":"10.1126\/scitranslmed.3008227"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lim LH, Pervaiz S: Annexin 1: the new face of an old molecule. FASEB J 2007; 21: 968-975.","DOI":"10.1096\/fj.06-7464rev"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Kim SD, Kim JM, Jo SH, Lee HY, Lee SY, Shim JW, Seo SK, Yun J, Bae YS: Functional expression of formyl peptide receptor family in human NK cells. J Immunol 2009; 183: 5511-5517.","DOI":"10.4049\/jimmunol.0802986"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Ichihara A, Wang Z, Jinnin M, Izuno Y, Shimozono N, Yamane K, Fujisawa A, Moriya C, Fukushima S, Inoue Y, Ihn H: Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions. J Allergy Clin Immunol 2014; 133: 1065-1074.","DOI":"10.1016\/j.jaci.2013.09.019"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Paquet P, Paquet F, Al Saleh W, Reper P, Vanderkelen A, Pierard GE: Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis. The American Journal of dermatopathology 2000; 22: 413-417.","DOI":"10.1097\/00000372-200010000-00005"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Viard-Leveugle I, Gaide O, Jankovic D, Feldmeyer L, Kerl K, Pickard C, Roques S, Friedmann PS, Contassot E, French LE: TNF-alpha and IFN-gamma are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis. J Invest Dermatol 2013; 133: 489-498.","DOI":"10.1038\/jid.2012.330"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Chung WH, Hung SI: Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis. J Dermatol Sci 2012; 66: 190-196.","DOI":"10.1016\/j.jdermsci.2012.04.002"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Tapia B, Padial A, Sanchez-Sabate E, Alvarez-Ferreira J, Morel E, Blanca M, Bell\u00f3n T: Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol 2004; 114: 335-340.","DOI":"10.1016\/j.jaci.2004.04.034"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Su SC, Chung WH: Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions. Toxins (Basel) 2014; 6: 194-210.","DOI":"10.3390\/toxins6010194"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Morel E, Alvarez L, Cabanas R, Fiandor A, Diaz R, Escamochero S, Prior N, Blanca M, Bell\u00f3n T: Expression of alpha-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions. Allergy 2011; 66: 360-367.","DOI":"10.1111\/j.1398-9995.2010.02484.x"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/83\/6\/83_216\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:55:01Z","timestamp":1568768101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/83\/6\/83_216\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.83.216","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}